Patent 9968595 was granted and assigned to Agios Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office.
Provided are compounds and pharmaceutical compositions useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound or pharmaceutical composition described herein.